EMEA-001740-PIP01-14
Key facts
| Active substance |
vaborbactam
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0230/2015
|
| PIP number |
EMEA-001740-PIP01-14
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of Gram-negative bacterial infections
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Rempex Pharmaceuticals, a wholly-owned subsidiary of The Medicines Company
Tel. +39 0555680633 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|